Lesson Learned from Mass Antibody Rapid Diagnostic Used in the Early COVID-19 Pandemic in Indonesia Contributors.
Agnes Rengga IndratiLuhung BudiailmiawanLouisa MarkusJohanis JohanisVerina Logitonull AryatiPublished in: Medical devices (Auckland, N.Z.) (2024)
The variations in the RDT antibodies'performance can cause errors in diagnosis leading to significant material and immaterial losses. Therefore, cooperation from various parties is needed for the pre- and post-marketing surveillance process to assess the performance and the characteristics of each RDT kit and other diagnostic methods to assist the rapid pandemic response process.